跳至主要内容
临床试验/NL-OMON25666
NL-OMON25666已完成不适用

An observational controlled study on vaginal blood flow and sexual functioning after early stage cervical cancer treatment.

eiden University Medical Center (LUMC), Leiden, The Netherlands.0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Eligible women are: treated for early stage cervical cancer (FIGO IA2 – IIA) at least 12 months before; treated with conventional radical hysterectomy with pelvic lymphadenectomy using the Okabayashi method (RHL-WO) at the AMC; younger than 52 years old; pre-menopausal; and have a performance status of WHO 1-2 and Karnofsky >60. Women are selected on menopausal status, because this can have influence on the vaginal perfusion response. In case eligible women of 40-52 years old that menstruated regularly before the RHL-WO, and report menopausal complaints, LH and FSH-values are measured by taking a blood sample so that their menopausal status could be established.

排除标准

  • Exclusion criteria are: signs of recurrent or metastatic cervical cancer after 1 year; treatment with external beam radiation therapy, intravaginal brachytherapy and/or concomitant chemotherapy; removed ovaries during surgery; not being able to understand, read and write the Dutch language; and being pregnant. Use of medication and hormonal substitutes is registered.

研究者

发起方
eiden University Medical Center (LUMC), Leiden, The Netherlands.

相似试验